The federal government can make it easier and more affordable for individuals to reduce their own COVID-19 risk and take action to support public health.
The House-passed bill expands insurance coverage, reduces prescription drug costs, and makes crucial investments in maternal and public health.
The Rev. Jane Field of the Maine Council of Churches shares her thoughts on Maine’s approach to containing COVID-19, as well as the response from religious communities in the state.
Jill Rosenthal discusses the efficacy of COVID-19 vaccine mandates.
To meaningfully improve the health of Americans, new policies must target all of the drivers of health, including education, economic stability, neighborhoods and environments, social and community well-being, and historic inequities.
By addressing key priorities, the budget reconciliation process can advance health and economic recovery and deliver benefits to the individuals, neighborhoods, and communities that need them the most.
Reducing prescription drug prices does not have to come at the price of pharmaceutical innovation.
Value-based pricing aligns prescription drug prices to their clinical benefits, leading to lower spending and better health outcomes.
Extending comprehensive coverage to the 2.2 million uninsured adults in the Medicaid coverage gap would lessen medical debt and lead to fewer evictions.
The Medicaid coverage gap, which leaves more than 2 million people uninsured, must be closed with a comprehensive, permanent solution.